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function
Malou Zuidscherwoude 1,2, Elizabeth J. Haining1, Victoria A. Simms 1, Stephanie Watson1, Beata Grygielska1, 
Alex T. Hardy1, Andrea Bacon3, Stephen P. Watson1,2, & Steven G. Thomas 1,2*
1Institute of Cardiovascular Sciences, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK, 2Centre of Membrane 
Proteins and Receptors (COMPARE), University of Birmingham and University of Nottingham, Midlands, UK, and 3Genome Editing Facility, Technology 
Hub, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK
Abstract
An organized and dynamic cytoskeleton is required for platelet formation and function. 
Formins are a large family of actin regulatory proteins which are also able to regulate micro-
tubule dynamics. There are four formin family members expressed in human and mouse 
megakaryocytes and platelets. We have previously shown that the actin polymerization activity 
of formin proteins is required for cytoskeletal dynamics and platelet spreading using a small 
molecule inhibitor. In the current study, we analyze transgenic mouse models deficient in two 
of these proteins, mDia1 and Fhod1, along with a model lacking both proteins. We demon-
strate that double knockout mice display macrothrombocytopenia which is due to aberrant 
megakaryocyte function and a small decrease in platelet lifespan. Platelet function is unaf-
fected by the loss of these proteins. This data indicates a critical role for formins in platelet and 
megakaryocyte function.
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Introduction
Megakaryocytes and platelets require a dynamic and properly 
regulated actin cytoskeleton for megakaryocyte development, 
platelet formation, and platelet function. In megakaryocytes, cyto-
plasmic maturation via endomitosis and the formation of the 
demarcation membrane system are both dependent on the cytos-
keleton [1,2] as are proplatelet extension, branching, and platelet 
release [3–5]. The importance of a dynamic cytoskeleton in 
platelet formation is evidenced by the identification of mutations 
in multiple cytoskeletal regulatory proteins which result in throm-
bocytopenia [6,7]. Likewise, the role of the actin cytoskeleton in 
the maintenance of platelet shape on its journey through the 
circulation and upon platelet activation is well established. The 
cytoskeleton is critical for shape change, spreading, and clot 
retraction [8,9], and is regulated by a plethora of actin binding 
and regulatory proteins, and disruption to these often results in 
defects of platelet function (e.g [6,10,11]).
Formins are a class of actin-binding proteins known as nuclea-
tion-promoting factors, although they have been shown to have 
functions beyond simple nucleation. Members of the formin pro-
tein family have the ability to both nucleate and accelerate the 
elongation of linear actin fibers and are also involved in micro-
tubule dynamics and organization [12]. Formins are increasingly 
recognized as regulators of cross-talk between the actin and 
microtubule cytoskeletons and they can therefore be expected to 
play a role in multiple aspects of platelet formation and function 
[13]. Indeed, a gain of function variant of formin mDia1 
(DIAPH1) is linked to macrothrombocytopenia in humans 
[14,15]. Of the 15 mammalian formins, only 4 are expressed in 
platelets and megakaryocytes, namely mDia1, Fhod1, Daam1, 
and Inf2 which contribute 24.5%, 36.7%, 14.5%, and 24.3%, 
respectively, of the total formin protein expressed in mouse plate-
lets [13,16]. We have previously shown that platelets from an 
mDia1 knockout mouse were functionally normal and hypothe-
size that this was due to redundant function with other platelet/ 
megakaryocyte expressed formin family members [16]. In support 
of this, we have recently reported that blocking formin FH2 
domains using a small molecule inhibitor (SMIFH2) completely 
abolishes platelet spreading and disrupts microtubule dynamics 
[17], highlighting the role of formins in regulating both actin and 
microtubule platelet cytoskeletons.
In the current study we generated a Fhod1-deficient transgenic 
mouse model, and subsequently crossed this with the mDia1- 
deficient mouse to generate a double mDia1/Fhod1-deficient 
mouse. This allowed us to assess the effect of loss of these formin 
family members on platelet formation and function. Here we 
show that loss of both mDia1 and Fhod1 results in macrothrom-
bocytopenia due to defective platelet production. However, plate-
let function is unaffected by the loss of these two proteins.
Methods
Generation of mDia1 and Fhod1 Knockout Mouse Models
Constitutive Fhod1 knockout mice were generated by injection of 
gene-trapped embryonic stem cells into blastocyst stage embryos 
derived from super-ovulated female mice using methods as 
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previously described [18]. Gene trapped ES cells for Fhod1 
(IST13553G8) were obtained from the Texas Institute for 
Genomic Medicine (https://www.tigm.org). Details of the gene 
trap vector and genotyping of the mice are given in supplemen-
tary figures (Supp. Fig1 & 2). mDia1 knockout mice were pro-
vided by Prof. Art Alberts (generated as previously described 
[19]). All mice were on a C57BLK6 background. Animals were 
maintained using housing and husbandry in accordance with local 
and national legal regulations and all work was performed under 
appropriate Home Office licenses on mice between 8 and 
24 weeks of age and littermates were used as wild type controls. 
Calculations of Mendelian inheritance patterns for mDia1 and 
Fhod1 transgenic mice were carried out as per [20].
Platelet Preparation
Blood was drawn from the vena cava of CO2 narcosed mice directly 
into 100 μL acid/citrate/dextrose (ACD). The number and size of 
platelets in whole blood was determined using an ABX Micros 60 
hematological analyzer (ABX Diagnostics, Montpelier, France). 
PRP was obtained by centrifugation at 200x g for 6 min. Washed 
platelets were prepared via centrifugation of PRP at 1000x g in the 
presence of 0.1 µg ml−1 prostacyclin (Caymen Chemicals) for 
6 min. The platelet pellet was resuspended in modified Tyrodes 
buffer (134 mM NaCl, 0.34 mM Na2HPO4, 2.9 mM KCl, 12 mM 
NaHCO3, 20 mM HEPES, 5 mM glucose, 1 mM MgCl2; pH 7.3) 
and platelet counts determined using a Coulter counter (Beckman 
Coulter). Platelets were left to rest for 30 min and count was 
adjusted as required using modified Tyrodes buffer.
Platelet Spreading
For fixed cell immunofluorescence imaging, platelets were 
diluted to 2 × 107 ml−1 in modified Tyrode’s buffer and allowed 
to spread on fibrinogen (100 µg ml−1) (Enzyme Research) or 95% 
Type I, 5% Type III (Horm) collagen (10 µg ml−1) (Takeda/ 
Nycomed) coated coverslips for 45 min at 37°C, 5% CO2. 
Where indicated, platelets were pre-activated with 0.1 U ml−1 
thrombin (Sigma) prior to plating on fibrinogen coverslips. At the 
end of the incubation, non-adhered platelets were removed by 
washing once in PBS and then fixed for 10 min in 10% neutral- 
buffered formalin (Sigma-Aldrich).
For resting platelet and chilled platelet imaging experiments, 
washed platelets at 4 × 107 ml−1 were incubated at 37°C or 4°C 
for 3 h prior to fixation. A further aliquot of platelets stored at 4° 
C for 3 h were then re-warmed to 37°C for 30 min before fixation 
in an equal volume of 10% neutral-buffered formalin for 15 min. 
Fixed platelets were added to a 24-well plate containing poly- 
L-lysine (Sigma) coated glass coverslips and centrifuged to 
immobilize platelets.
Immuno-labeling
Following PBS washes cells were permeabilised with 0.1% (v/v) 
Triton X-100 for 5 min and then washed in PBS and blocked for 
30 min in block buffer (1% BSA, 2% goat serum in PBS). Tubulin 
was immunolabelled with 2 µg ml−1 anti-α-tubulin (Clone 
DM1A, Sigma-Aldrich) diluted in block buffer for 1 h at room 
temperature. Tubulin was secondary labeled with 4 µg ml−1 anti- 
mouse-Alexa647 and F-actin was labeled with 13 nM phalloidin- 
Alexa488 (Thermo-Fisher). Cells were washed in PBS and 
mounted in Hydromount (National Diagnostics) prior to imaging.
SDS-PAGE and Western Blotting
Lysates from resting platelets were prepared from platelets at 
5 × 108 ml−1 in an equal volume of 2x lysis buffer on ice for 
10 min. Lysates were mixed with sample buffer and boiled for 
5 min before cooling. Samples and protein marker were loaded 
into wells of pre-cast polyacrylamide gels (Bolt, Invitrogen) at 
60 V for 15 min to stack proteins, followed by 120 V for 1 h for 
separation. Proteins were transferred to PVDF membranes for 
10 min using the Trans-Blot Turbo Transfer System (Bio-rad), 
then incubated for 1 h at room temperature in blocking buffer (5% 
BSA in TBST, filtered). Blots were incubated with primary anti-
bodies against either mDia1 (Bethyl Labs, A300-078A), Fhod1 
(Abcam, ab73443), or Daam1 (Clone 5D3, ECM Biosciences) at 
2 μg ml−1 in blocking solution at 4°C overnight. Blots were 
washed 3 times for 10 min each in TBST, then incubated for 1 
h with anti-mouse or anti-rat secondary antibody, diluted 1:10 000 
in TBST, before a further 3 washes. Using LI-COR Odyssey 
imaging system and Image Studio software, western blots were 
exposed for 2–10 min.
Platelet Aggregation and Secretion
Platelet aggregation and dense granule ATP secretion were mon-
itored using 300 µL of washed platelets at 2 × 108 mL−1. 
Stimulation of platelets with thrombin (0.03 or 0.1 U mL−1) or 
95% Type I, 5% Type III (Horm) collagen (0.3 or 3 µg mL−1) was 
performed in a Lumi-Dual Aggro-meter (Chrono-Log 
Corporation) with continuous stirring at 1200 rpm at 37°C. ATP 
secretion was determined during aggregation using Chrono-Lume 
reagent (Chrono-Log Corporation).
In Vitro Flow Studies
For flow adhesion studies, mouse blood was drawn into sodium 
heparin (10 IU ml−1) and PPACK (40 μM). Vena8 Fluoro+ 
biochips (Cellix) were coated with 100 μg ml−1 95% Type I, 
5% Type III (Horm) collagen, (Nycomed, Munich, Germany) for 
1 h at room temperature. The chips were washed and blocked 
with PBS containing 5 mg ml−1 BSA for 1 h at room tempera-
ture. Anticoagulated whole blood, labeled with DiOC6 (final 
concentration 2 µM) for 10 min was perfused through the cham-
ber for 6 min at a wall shear rate of 1000 s−1, followed by 
washing for 3 min at the same shear rate with modified 
Tyrodes buffer. Ten FOV were captured along the length of the 
biochip and the percentage surface area coverage calculated 
using Fiji [21]. Images were background subtracted, and then 
converted into binary images using the Otsu threshold function. 
Measurement of the platelet aggregates in each image was 
obtained using the Analyze Particles function and overall surface 
area coverage in each image calculated by summing the indivi-
dual thrombi.
Flow Cytometry
The receptor levels on the surface of resting platelets were deter-
mined by labeling 10 μL of washed platelets at 2 × 108 ml−1 with 
50 μL of Tyrodes containing 5 μl of the relevant FITC conjugated 
antibody (i.e. CD41, GPVI, CD49b, Clec2 or GPIbα; Emfret 
Analytics) and incubating in the dark for 30 min. Samples were 
diluted with 200 μl of modified Tyrodes buffer and analyzed 
using an Accuri C6 flow cytometer (BD Biosciences). Initial 
gating of platelets was performed using Forward Scatter/Side 
Scatter plots and then the fluorescence intensity (in FL1 channel) 
of 10,000 platelets in this gate was recorded for each sample. An 
isotype control antibody was used to subtract background and 
values presented as mean fluorescence intensity (MFI).
For P-selectin exposure and fibrinogen binding assays, plate-
lets were stimulated with 0.1 U ml−1 thrombin for 2 min at 37°C 
or with PBS (unstimulated controls) before staining with either 
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anti-P-selectin-FITC or Alexa488-fibrinogen for 30 min and 
flow cytometry as described above.
Clot Retraction
Whole murine blood was anti-coagulated with sodium citrate and 
PRP prepared as above. The platelet count was adjusted to 3 × 
108 ml−1 with modified Tyrodes Buffer containing CaCl2 (2 mM) 
and fibrinogen (2 mg ml−1). 400 μl of this mix was placed into an 
aggregometer tube and incubated at 37°C for 5 min. 2 μl of 
mouse erythrocytes were added for color contrast. Thrombin 
(10 U ml−1) was added and mixed with a paperclip and clot 
retraction was allowed to proceed at 37°C for 1 hour with the 
paperclip present. At appropriate time points, the clot was pulled 
out with the paperclip and the remaining serum volume measured.
Platelet Turnover and Immune-induced Thrombocytopenia
Platelet turnover was measured by injecting mice with 0.1 μg g−1 
body weight of GPIbβ DyLight488 conjugated antibody (Emfret 
Analytics; X488). Blood samples were taken from the tail vein at 
various time points after injection (1, 24, 48, 72, 96, and 120 h) 
and the percentage of DyLight488 labeled platelets was measured 
using an Accuri C6 flow cytometer.
To establish the dynamics of platelet production in these mice, 
platelets were depleted and their recovery monitored. A baseline 
platelet count was established by tail vein bleeds, after which 
immune-induced thrombocytopenia was induced in mice by tail 
vein injection of 2 μg g−1 body weight anti-GPIbα antibody 
(Emfret analytics; R300) followed by blood sampling at 1, 3, 5, 
7 10 and 14 days post-injection to determine the platelet recovery 
using an ABX Micros Pentra 60 hematological analyzer.
Bone Marrow Megakaryocyte Isolation, DNA Ploidy 
Measurement and Megakaryocyte Spreading Assays
Bone marrow megakaryocyte progenitor cells were isolated and 
cultured in vitro and mature megakaryocytes were enriched for 
via a BSA gradient as previously described [22]. For DNA ploidy 
measurements mature megakaryocytes were stained with anti- 
CD41-FITC (MWReg30, BD Biosciences), fixed in 0.5% PFA, 
and DNA labeled with propidium iodide overnight (PBS, 2 mM 
MgCl2, 0.05% saponin, 0.01 mg ml−1 propidium iodide and 10 U 
ml−1 RNAse). For DNA ploidy measurements of freshly isolated 
megakaryocytes, whole bone marrow was flushed from the femur 
and tibia in flushing buffer (PBS, 10% EDTA, 10% BSA, 1 M 
HEPES) and dissociated cells were stained with anti-CD42-FITC 
(Xia-H10, Emfret Analytics) in staining buffer (PBS, 2,5% FBS, 
5% EDTA, 5% BSA, 0.5 M HEPES), before DNA labeling as 
above. Cells were analyzed using a FACSCalibur flow cytometer 
(Becton Dickinson) by initially gating on the large granular popu-
lation on FSC/SSC plots and then measuring the propidium 
iodide intensity of CD41/CD42 positive cells (Supp. Fig 5C). 
Analysis was performed using FlowJo software.
For megakaryocyte spreading analysis, mature megakaryo-
cytes were allowed to spread on fibrinogen coated coverslips in 
the presence of SDF1α (0.25 μg mL−1; Peprotech) at 37°C/5% 
CO2 for 1 or 3 h, before fixing and immuno-labeling as described 
above. For proplatelet, formation assays heparin (70 U mL−1) was 
added during spreading.
Histology of Mouse Femur
Dissected mouse femurs were incubated overnight in 4% neutral- 
buffered saline containing 5 mM sucrose. Fixed femurs were 
decalcified in 10% EDTA/PBS and then processed for paraffin 
embedding. 10 µm longitudinal sections were stained with 
hematoxylin and eosin and imaged using a Zeiss Axio Scan.Z1. 
Megakaryocytes within the bone marrow were identified by mor-
phology and size. For each section, all megakaryocytes within the 
diaphysis of the femur were counted manually and results are 
presented as number of megakaryocytes per mm2.
Microscopy
Images were acquired using an Axio Observer 7 inverted epi-
fluorescence microscope (Carl Zeiss) with Definite Focus 2 auto-
focus, Colibri 7 LED illumination source, Hammamatsu Flash 4 
V2 sCMOS camera, Filter sets 38 and 50 for Alexa488 and 
Alexa647, respectively, and DIC optics. Acquisition was per-
formed using Zen 2.3 Pro software. For platelet imaging, 
a 63 × 1.4 NA oil immersion objective lens was used and for 
megakaryocyte imaging a 20 × 0.8NA air objective lens was 
used. LED power and exposure times were chosen to be appro-
priate for each set of samples but kept the same within each 
experiment. For platelet spreading experiments, five image stacks 
were taken per genotype from three independent experiments. For 
resting platelet experiments, five image stacks were taken per 
genotype from five independent experiments. For megakaryocyte 
spreading, 38–50 cells were captured per coverslip. For proplate-
let formation assays, a tiled image (6000 x 6000 μm) was cap-
tured per sample. For SR-SIM imaging, samples were imaged on 
a Nikon N-SIM-S microscope with Ti2-E inverted microsope 
stand, PFS4 focus stability system, 100 × 1.49 NA oil immersion 
objective lens with automatic correction collar adjustment, LU- 
NV-L laser bed, Hammamatsu Orca Flash 4 V3 sCMOS camera, 
TI2-FT N-SIM Motorized Filter set, and NIS-AR elements V5 
software. Additional image processing and measurements were 
performed using Fiji.
Image Analysis
Post-capture image analysis was performed using Fiji. For 
fixed cell measurements (surface area of spread or resting 
cells) data are from means from three or five independent 
experiments, respectively, with between 150 and 350 individual 
platelets analyzed for each treatment per experiment. The 
spread platelet and megakaryocyte area were measured using 
thresholding, ROI manager and Measure functions of Fiji. 
Distribution of platelet-spreading morphology and the classifi-
cation of proplatelet forming megakaryocytes was performed 
using a semi-automated workflow [23].
Statistics
Data analysis was carried out using Microsoft Excel and 
Graphpad Prism V6. Results are shown as mean ± SD, number 
of replicates (unless indicated), and statistical significance was 
analyzed using ANOVA or Kruskal–Wallis one-way analysis of 
variance (after determining whether data were normally distribu-
ted or not) and Dunnetts multiple comparison tests–effects were 
compared to WT. P values are given in the text whilst in figures is 
represented by stars compared to WT (P < .05 = *; P < .01 = **; 
P < .005 = ***; P < .001 = ****).
Results
Mouse Models
We have previously reported that platelets from an mDia1 knock-
out mouse model have no platelet function phenotype [16]. 
However, reports from shRNA knockdown of mDia1 in human 
CD34+ cells and patients expressing a gain of function mutation 
in mDia1 demonstrate an effect on platelet formation [14,24]. 
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Furthermore, we have recently demonstrated the importance of 
formin FH2 domains for platelet function through use of a global 
FH2 domain inhibitor [17]. Therefore, we generated a transgenic 
mouse model for the most abundant platelet formin, Fhod1 
(Fhod1 KO), which we have previously shown is activated upon 
platelet stimulation [16], and compared platelet function and 
formation to wild type (WT) mice. We also compared them to 
platelets and megakaryocytes from the mDia1 transgenic model 
(mDia1 KO) and a double mDia1/Fhod1 transgenic model (DKO) 
to investigate redundancy between the two formin proteins. 
Outwardly, all mouse models (mdia1KO, Fhod1 KO, and DKO) 
displayed no overt phenotype and inheritance of the mDia1 and 
Fhod1 alleles was Mendelian (Supp. Fig 2B).
Hematological Analysis of Knockout Mice
Detailed analysis of the hematological parameters of Fhod1 KO 
mice demonstrated that blood cell production in these mice was 
normal. They displayed a normal platelet count and platelet 
volume when compared to WT mice (Figure 1a & 1b), and the 
total number of white blood cells, and the proportion of each 
white blood cell type was normal (Supp. Fig 3A – F).
In contrast, both mDia1 KO and DKO mice displayed altered 
platelet count and platelet volume (Figure 1a & b). mDia1 KO 
mice had large platelets (P < .0001) with a small, but significant 
decrease in platelet number (P = .011) whilst DKO mice devel-
oped a more severe macrothrombocytopenia (37% reduction) with 
significantly decreased platelet number (P < .0001) and increased 
platelet volume (P < .0001). The loss of mDia1 has previously 
been reported to affect white blood cell numbers [19,25–27]; 
however, no differences were seen in our mDia1 mice. We did, 
however, observe a significant reduction in total white blood cell 
count in DKO mice compared to WT (P = .034) (Supp. Fig. 3A). 
Further investigation indicated that in DKO mice the percentage 
of lymphocytes was significantly reduced (P = .0025), and the 
percentage of neutrophils was significantly increased (P = .0063) 
Figure 1. Loss of mDia1 and Fhod1 affects platelet production and turnover. a) Whole blood platelet counts and b) mean platelet volume was 
determined for all genotypes. mDia1 KO and DKO mice displayed a macrothrombocytopenia which was more severe in the DKO mice. Each data point 
represents 1 mouse. c) DKO platelets had a significant increase in surface GPIbα levels. No significant difference was observed for other platelet 
surface receptors (n = 4). d) Resting platelets from both the mDia1 KO and DKO mice had significantly elevated levels of P-selectin exposure on their 
surface and enhanced fibrinogen binding compared to WT and Fhod1 KOs (n = 4). e) Platelet lifespan (n = 4) and f) platelet recovery from immune- 
induced thrombocytopenia (n = 6) indicated that DKO platelets have a significantly increased rate of clearance and a significantly decreased recovery 
compared to WT mice. Error bars represent mean ± SD for a) and b) and ± SEM for c-f).
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compared to WT. Levels of monocytes, basophiles and eosino-
phils were unaltered. This data indicates a role for the formins 
mDia1 and Fhod1 in maintenance of platelet number and volume, 
and in the proper development of WBCs.
Analysis of Resting Platelets
As we had observed a disruption in platelet number and 
volume, we investigated the resting platelet phenotype further. 
Analysis of the surface receptor expression profile by flow 
cytometry showed that, consistent with the hematological ana-
lysis, Fhod1 KO platelets were similar to WT in terms of CD41, 
CPVI, CD49b, CLEC2, and GPIbα expression (Figure 1c). 
Likewise, mDia1 KO platelets were indistinguishable from 
WT in terms of their surface receptor profile, despite having 
an increased platelet volume. In contrast, resting platelets from 
the DKO mice had significantly elevated levels of GPIbα on 
their surface compared to WT (P = .028) and Fhod1 KO (P = 
.002), although other receptor levels were similar to WT 
(Figure 1c, Supp. Fig. 4A). Surface GPIbα levels on mDia1 
KO platelets were intermediate between WT and DKO but not 
significantly different to either. Further investigation of the 
resting platelets showed that both mDia1 KO and DKO platelets 
had elevated surface levels of P-selectin (P < .0001) and 
increased fibrinogen binding capacity (P < .0001) compared 
to WT mice (Figure 1d).
Analysis of Platelet Clearance
As GPIbα has been implicated in mediating platelet clearance 
from the circulation [28], and it is believed that P-selectin surface 
expression may enhance platelet clearance by leukocytes [29], we 
monitored the platelet population half-life in these mice. Whilst 
mDia1 KO and Fhod1 KO mice almost exactly overlaid the WT 
(Supp. Fig 4B), we observed a very small, but significant increase 
in platelet clearance for DKO mice at day 2 (P = .0026) and day 3 
(P = .0146) when compared to WT (Figure 1e). This suggests 
that the increased GPIbα levels and not the elevated P-selectin on 
resting platelets that, at least in part, is responsible for the 
observed thrombocytopenia in the DKO mice.
Analysis of Platelet Production
Thrombocytopenia can also be caused by a reduction in platelet 
production. As mutations in mDia1 have previously been impli-
cated in reduced proplatelet formation [14,24] we monitored 
platelet recovery following immune-induced thrombocytopenia. 
All genotypes displayed a rapid reduction in platelet count and 
subsequent recovery with no significant difference observed 
between either mDia1 KO or Fhod1 KO mice and WTs (Supp. 
Fig 4C). However, DKO mice did not display a rebound increase 
as seen in WT mice resulting in a significant reduction in platelet 
count at both day 8 (P = .031) and day 10 (P = .0003) post 
depletion (Figure 1f). Although this is a mild reduction in platelet 
production, a combination of a slight increase in clearance rate is 
likely to account for the reduction in platelet number observed in 
the DKO mice.
Effect of Loss of Formins on Megakaryocytes
To further investigate the effects of loss of these proteins on platelet 
production and megakaryocyte development, we prepared bone 
marrow sections from the femurs of these mice and counted the 
number of mature megakaryocytes in these sections. We observed 
no significant difference between the four genotypes in the number 
of megakaryocytes observed (Figure 2a, Supp. Fig. 5A).
In light of this, we further characterized bone marrow mega-
karyocyte development by isolating mature megakaryocytes from 
bone marrow of the femur and tibia of the mice. Firstly, the 
proportion of bone marrow cells that were identified as megakar-
yocytes reflected the counts made from bone femur sections and 
no significant difference between the genotypes was observed 
(P = .065) (Supp. Fig. 5B). To characterize megakaryocyte devel-
opment, we performed DNA ploidy measurements on these 
freshly isolated megakaryocytes. For Fhod1 KO mice, as 
expected from the normal platelet counts, no difference was 
observed in MK ploidy compared to WT (Figure 2b, Supp. Fig 
5D-E). However, for both mDia1 KO and DKO mice, there was 
a significant increase in the proportion of 8 N megakaryocyte 
(mDia1 P = .04, DKO P = .0001) and a significant decrease in 
the proportion of 32 N+ megakaryocytes (mDia1 P = .0071, 
DKO P = .0019) compared to WT (Figure 2b). This indicates 
that whilst there is no difference in the total numbers of mega-
karyocytes in the bone marrow, megakaryocytes differentiation, 
as measured by DNA ploidy, is reduced.
To investigate this effect further we isolated lineage negative 
bone marrow cells and differentiated them in vitro before measur-
ing DNA ploidy profiles. However, megakaryocyte differentiation 
and DNA ploidy in in vitro cultured megakaryocytes showed no 
major differences between the genotypes (Supp. Fig 5F), indicat-
ing that formins may be important in sensing aspects of the bone 
marrow environment in vivo.
The ability of megakaryocytes to undergo proplatelet formation 
was assessed using proplatelet assays and an image analysis work-
flow [23] (Supp. Fig. 6A-C). For Fhod1 KO cells, no difference in 
the % of cells classified as proplatelet forming compared to WT was 
observed (Figure 2c). Interestingly, the surface area of proplatelet 
forming cells was significantly increased compared to WT 
(P = .0003, Figure 2d). In line with the observed thrombocytopenia, 
both mdia1 KO and DKO megakaryocytes showed a reduction in 
the number of cells undergoing proplatelet formation (Figure 2c) 
although this was only significant for the DKO (P = .04). DKO 
cells also displayed a significant reduction in the surface area of 
proplatelet forming cells (P = .0054, Figure 2d). This reduction in 
proplatelet formation, along with the increase in platelet clearance, 
may underlie the observed thrombocytopenia in these mice.
To test if loss of formin proteins has an effect on the ability of 
megakaryocytes to organize their actin and hence their ability to 
spread, mature megakaryocytes were allowed to spread on fibri-
nogen for 1 or 3 h. The average surface area of both mDia1 KO 
and DKO cells was reduced compared to controls at both 1 h 
(mDia1 KO P = .0012, DKO P = .0008) and 3 h (mDia1 KO 
P = .0016, DKO P = .0003) (Figure 2e & Supp. Fig 6D). This, 
therefore, indicates that megakaryocyte spreading on fibrinogen is 
partially formin mediated. Although spreading is not required for 
platelet production in vivo, this suggests that mDia1 and Fhod1 
are required for normal megakaryocyte actin organization during 
platelet production.
Taking the data all together indicates that mDia1 KO and 
DKO mice have decreased platelet count, increased platelet size, 
and increased surface levels of GPIbα and platelet activation 
markers. DKO mice have altered kinetics of platelet count, 
namely, slightly increased platelet clearance and delayed platelet 
recovery. Therefore, it is likely that formins play a role in mediat-
ing megakaryocyte cytoskeletal dynamics and differentiation 
in vivo which contributes to the observed 
macrothrombocytopenia.
Role of Formins in Regulating the Platelet Cytoskeleton
We have recently showed that blocking formin-mediated actin 
polymerization using a selective inhibitor blocks platelet 
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spreading and causes increased coiling of the platelet microtubule 
coil [17]. To establish the effect that loss of specific formin 
proteins have on the organization of the resting platelet cytoske-
leton, we stained fixed, resting platelets with α-tubulin antibodies 
and used SIM imaging to visualize the microtubule coil. WT 
platelets displayed a distinct coil at the periphery of the platelet, 
and evidence for microtubules extending throughout the cyto-
plasm of the platelet (Figure 3a, top panel). Resting platelets 
from mDia1 KO, Fhod1 KO, and DKO mice also displayed 
microtubule coils, although qualitatively, the staining gave 
a more “patchy” pattern than in WT platelets and there was 
evidence for more disorganized microtubules within the center 
of the platelets, especially in Fhod1 KO platelets (Figure 3a, 
Lower three panels). However, this disruption was not as evident 
as that observed in platelets of human patients with a DIAPH1 
gain of function mutation [14]. An additional feature describing 
platelets of patients with DIAPH gain of function was that the 
microtubule coil was protected from depolymerization upon chil-
ling. To test this we stored platelets from our mouse models at 
either 37°C or 4°C prior to fixation and then stained them for 
microtubules and imaged using widefield fluorescence micro-
scopy (Figure 3b). The surface area of resting platelets, outlined 
by the microtubule coil, confirmed the increased size of mDia1 
KO and DKO platelets compared to WT and Fhod1 KO cells. 
(Figure 3c). As expected, the surface area of platelets chilled at 4° 
C for 3 h was much smaller than platelets stored at 37°C for all 
Figure 2. Loss of mDia1 and Fhod1 causes a developmental defect in bone marrow megakaryocytes. a) Counts of megakaryocytes in bone marrow 
of femur sections showed no significant difference between any of the genotypes tested. Each data point represents 1 mouse. b) The DNA ploidy level 
of megakaryocytes freshly isolated from bone marrow showed that both mDia1 KO and DKO mice had significantly increased levels of 8 N cells and 
significantly decreased levels of 32 N+ cells in their bone marrow (n = 3). c) The percentage of cells classified as proplatelet forming (PPF) by image 
analysis was reduced in both mDia1 and DKO mice (n = 3). d) The surface area of PPF cell is reduced in DKO mice. Each data point represents 1 cell 
(pooled data from the 3 mice). e) Surface area quantification of mature megakaryocytes spread for 1 and 3 h indicated that both mDia1 KO and DKO 
cells has a reduced ability to spread (n = 2). Error bars represent mean ± SEM for a), b), c) & e) and mean ± SD for d).
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genotypes. There was no significant difference between the gen-
otypes at 4°C (Figure 3c). Qualitative analysis of the images from 
these experiments showed that although occasional platelets with 
residual coils could be identified, the microtubule coils of mDia1 
KO, Fhod1 KO and DKO mice generally depolymerized to the 
same extent as WT (Figure 3b). Rewarming of chilled platelets to 
37°C allowed re-polymerization of the microtubule coil in all 
genotypes (Figure 3b). Interestingly, the rewarmed platelets did 
not return to their original size and surface areas were slightly 
reduced compared to un-chilled resting platelets (Figure 3c). In 
addition, the differences observed between mDia1 KO and DKO 
and WT platelets were lost. Together this indicates that the 
microtubules in these cells are “normal” and any difference in 
resting platelet size is likely due to issues in platelet production or 
in how motor proteins interact with the coil.
Formins are actin nucleation-promoting factors and we have 
previously demonstrated the role of FH2 domains in regulating 
platelet spreading [17]. Therefore, we monitored the effect of the 
loss of mDia1, Fhod1, or both proteins on platelets spreading. 
Confirming our previous studies [16], the loss of mDia1 has no 
Figure 3. Loss of mDia1 and Fhod1 has no effect on cold-induced microtubule ring depolymerization. a) Representative SIM images of the 
microtubule coils of resting platelets. b) Resting platelets from WT, mDia1 KO, Fhod1 KO or DKO mice were stored at either 37°C or 4°C for 3 h. 
A subsample was also re-warmed to 37°C for 30 min. After fixing platelets were labeled for tubulin and b) resting platelet surface area was determined. 
Each data point represents 1 mouse. Scale bars = 5 μm. Error bars represent mean ± SEM.
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effect on platelet spreading on any of the surfaces tested. 
Similarly and surprisingly, knockout of Fhod1 or both mDia1 
and Fhod1, had no effect on platelet spreading in terms of spread 
surface area (Figure 4a) or in the distribution of spreading 
morphologies displayed (Figure 4b). Furthermore, SR-SIM ima-
ging of F-actin and microtubules demonstrates that platelets from 
all genotypes are capable of forming actin nodules, filopodia, 
lamellipodia, stress fibers, and that microtubule coils reorganize 
to form characteristics spread platelet networks (Figure 4c, Supp. 
Fig. 7).
Role of Formins in Regulating Platelet Function
Platelets from the knockout models were compared to WT plate-
lets in a range of platelet function assays. No significant differ-
ences were observed between WT and mDia1 KO, Fhod1 KO, or 
DKO platelets in aggregation, ATP secretion, P-selectin exposure, 
fibrinogen binding, aggregation to collagen under flow, or clot 
retraction. A summary of the data for these experiments can be 
found in Table I and Supp. Fig. 8.
Taken together this data indicates that mouse platelets can 
tolerate the loss of both mDia1 and Fhod1, indicating that formin 
function in platelets can be sufficiently covered by another formin 
family member, or more generally by other actin regulatory path-
ways during platelet activation.
Discussion
In this manuscript, we report the platelet and MK phenotype of 
a Fhod1 KO and a double Fhod1 and mdia1 KO mouse model. 
These mice are compared to the previously characterized mDia1 
KO mice [16] and to WT mice.
Figure 4. Loss of mDia1 and Fhod1 has no 
effect on platelet spreading. a) Analysis of 
spread platelet surface area and b) spread plate-
let morphology of washed platelets from WT, 
mDia1 KO, Fhod1 KO or DKO mice spread for 
45 min on (i) fibrinogen, (ii) fibrinogen + 
thrombin and (iii) collagen (n = 4). No signifi-
cant difference in surface area or morphology 
was observed. c) Representative images of pla-
telets spread on fibrinogen for 45 min, fixed, 
stained for actin and tubulin, and imaged using 
SR-SIM. Scale bars = 5 μm. Error bars repre-
sent mean ± SEM in A) mean ± SD in B).
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The clearest defect observed is disrupted platelet production 
with a decreased platelet count being observed, which is most 
severe in the DKO mice. The evidence presented here suggests 
that mDia1 is the major player in this phenotype, as mDia1 KOs 
show a tendency toward thrombocytopenia, which is exacerbated 
by the loss of Fhod1 in the DKOs. In contrast, Fhod1 KO mice 
alone display no change in platelet number strongly suggesting 
that Fhod1 contributes, but does not play a major role in this 
process. In addition to the reduced production of platelets in 
mDia1 KO and DKO mice, there are also disruptions to the 
process which results in enlarged platelet size, and perturbed 
surface receptor profiles.
The reason for thrombocytopenia in these mice is likely to be 
multi-factorial and a combination of both decreased production 
and increased clearance. We demonstrated that DKO mice have 
disrupted megakaryocyte development and platelet production, 
data which is in line with that from gain of function mutations 
and knockout of DIAPH1 [14,24]. The mechanisms underlying 
normal proplatelet formation are complex, but it is clear that 
both the microtubule and actin cytoskeletons are required [6]. 
Recent work has identified that both post-translational modifica-
tions of tubulin [30,31] and interactions between cytoskeletal 
motors, the cytoskeleton, and response to the environment (e.g. 
flow) [32] modulate platelet formation. Formins have important 
roles to play in polymerization of actin filaments, organizing 
actin and microtubules [13], and in regulating both actin and 
tubulin post-translation modification [33,34] and so the effects 
on proplatelet formation is likely to be based on multiple 
mechanisms.
Alongside the changes in platelet formation, the observed 
increased basal expression of GPIbα could enhance CR3- 
mediated macrophage clearance of platelets in the liver [28], 
which along with increased P-selectin-mediated clearance of rest-
ing platelets by neutrophils [29,35], could contribute to the 
observed thrombocytopenia. Platelet half-life experiments would 
seem to support this hypothesis as DKO mice have a very small, 
but significant increase in platelet clearance. Interestingly, mDia1 
KO mice showed similar kinetics of platelet clearance to WT 
mice (data not shown). mDia1 KO platelets showed a similar 
level of P-selectin expression as DKO platelets, but a reduced 
GPIbα expression, indicating that it is the enhanced GPIbα levels 
that are the primary driver of the observed platelet clearance in 
DKO mice. Our observation that neutrophil proportion is 
increased in DKO, but not mDia1 KO mice seems at odds with 
this; however, it has been reported that aberrant formin activity 
can give rise to myeloproliferative defects [27], and therefore the 
situation with regards to altered leukocyte populations may be 
complex.
Increased GPIbα expression on platelets might also be 
expected to enhance initial binding to Von Willebrand factor 
upon exposure to collagen. However, in vitro flow experiments 
of whole blood over collagen-coated chambers indicated no sig-
nificant effect of this increased GPIbα on aggregate formation 
(Table I and Supp. Fig. 8). Whether this small increase in GPIbα 
is sufficient to cause reduced time to clot in vivo, is unclear. 
Furthermore, increased expression of P-selectin on resting plate-
lets from mDia1 KO and DKO mice might indicate enhanced 
alpha granule secretion; indeed P-selectin expression in activated 
platelets was increased in these mice; however, this was not 
significantly different to WT. Enhanced alpha granule secretion 
would lead to enhanced release of pro-thrombotic and pro- 
inflammatory mediators leading to the formation of platelet 
micro-aggregates or platelet-leukocyte, monocyte, and neutrophil 
aggregates and increased thrombotic risk. However, we did not 
test the levels of these factors directly in our mice.
We also investigated whether MK development and platelet 
production were affected by the loss of mDia1 and Fhod1. 
Previous studies have indicated that disruption to mDia1 (either 
knockdown, or gain of function) can disrupt this process [14,24]. 
Whilst we observed normal numbers of MKs in bone marrow 
sections, we report a reduction in MK spreading and the level of 
polyploidization in mDia1 KO and DKO mice. These data indi-
cated that both mDia1 and Fhod1 activity in MKs is required for 
normal development and actin dynamics. Interestingly, this 
Table I. Summary of platelet function testing data.
(Mean ± SEM) WT mDia1 KO Fhod1 DKO
Aggregation 
(% at 5 min) 
Coll 0.3 μg ml−1 
Coll 3 μg ml−1 
Thr 0.03 U ml−1 
Thr 0.1 U ml−1
18.7 ± 7.1 
61.9 ± 4.1 
7.2 ± 4.8 
65.0 ± 3.3
21.8 ± 9.9 
54.6 ± 11.9 
7.2 ± 6.9 
65.0 ± 3.4
10.0 ± 4.1 
46.8 ± 8.3 
6.9 ± 5.8 
59.2 ± 4.2
20.5 ± 5.1 
62.6 ± 4.7 




Coll 0.3 μg ml−1 
Coll 3 μg ml−1 
Thr 0.03 U ml−1 
Thr 0.1 U ml−1
0.114 ± 0.04 
0.979 ± 0.20 
0.004 ± 0.004 
1.181 ± 0.28
0.138 ± 0.06 
0.638 ± 0.17 
ND 
0.950 ± 0.44
0.020 ± 0.02 
1.150 ± 0.29 
ND 
1.319 ± 0.34
0.092 ± 0.04 
0.878 ± 0.09 









1319 ± 515 3139 ± 1309 2135 ± 1075 1875 ± 612
Aggregation under flow (surface area, μm2) 
Collagen @ 1000s−1
8759 ± 1981 8732 ± 1935 10 895 ± 1595 11 999 ± 2617
Clot retraction 




0.175 ± 0.006 








0.191 ± 0.003 
0.247 ± 0.014 
0.274 ± 0.009
ND – not detected; NA – not performed 
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difference in ploidy was only observed in MKs freshly isolated 
from bone marrow and not when lineage negative cells were 
differentiated in vitro. RhoA/mDia1 has been shown to play 
a role in crosstalk between force sensing and signal transduction 
pathways [36]. Whilst this might indicate a possible role for 
formins in the mechanosensing or mechanotransduction of envir-
onmental signals to the developing MK that modulate differentia-
tion, the reason for the lack of consistency between freshly 
isolated and ex vivo differentiated MKs remains unclear.
It is obvious that the role of Fhod1 in MKs and platelets is 
limited, compared to that for mDia1. This is supported by our 
observations that Fhod1 KO mice are more like WT mice than 
mDia1 KO or DKO. Fhod1 has been demonstrated to be required 
for stress fiber and podosome formation and dynamics in several 
cell types [37–39]. It has also been shown to be required for 
proliferation, epithelial-mesenchymal transition, tumor growth, 
invasion, and cell migration in several cancer lines [40–42]. We 
would have therefore expected Fhod1 might be of relevance in 
MKs, especially in the context of MK and proplatelet protrusion 
into the vasculature. It would appear from our data; however, that 
this is not the case, or this function can adequately be maintained 
by other actin regulatory proteins.
A particularly surprising outcome from the DKO mice is the 
lack of any clear functional platelet defect. Considering the potent 
roles for formin proteins in other cell types, the most likely 
explanation for the lack of effect here is redundancy. Our previous 
data mining of the mouse platelet proteome [13,43] indicated that 
there are 4 formin proteins expressed in mouse platelets; Daam1 
(8529 copies, 14.5% of total formin expression), mDia1 (14 408, 
24.5%), Fhod1 (21 598, 36.7%) and Inf2 (14 269, 24.3%). 
Therefore, DKO platelets still retain approximately 40% of their 
formin protein content, albeit with a different protein profile. We 
saw no evidence for the up-regulation of Daam1 in our mice 
(Supp. Figure 2B). Although different formin proteins have been 
associated with different cellular functions [44], the key charac-
teristic of a formin is the presence of FH1 & FH2 domains which 
together mediate the nucleation and elongation of actin filaments 
[45]. It is probable that 40% formin mediated-actin polymerizing 
activity, alongside redundancy between actin polymerization reg-
ulatory pathways, is sufficient for “normal” platelet function. 
Indeed, there are examples of formin redundancy recorded in 
the literature [46], and this hypothesis fits with our observation 
of a dose-dependent effect on platelet spreading of the FH2 
domain inhibitor SMIFH2 [17]. It is interesting to note that in 
patients with a DIAPH1 gain of function mutation, a similar 
effect was observed; namely, disrupted platelet production, but 
a relatively mild platelet functional defect [14], and in Arp2/3 
knockout mice, twinfilin/cofilin1 double knockout mice and 
ADF/cofilin knockout mouse, similar discrepancies between 
alterations to platelet production and mildly affected hemostasis 
are observed [47–49].
Further evidence to support this notion can be found by look-
ing in more detail at the molecular function of the two remaining 
proteins, Daam1 and Inf2. Daam1 is released from its auto- 
inhibited state by the combined actions of Disheveled (Dvl) and 
RhoA [50]. RhoA is activated upon platelet stimulation (reviewed 
by [51]), and work by Steele et al. demonstrated that upon platelet 
activation Dvl associated with Daam1. Therefore, it is highly 
likely that Damm1 would be contributing to actin polymerization 
in activated platelets. To the best of our knowledge, Inf2 has not 
been studied in platelets and so the contribution of this formin to 
platelet organization is unclear. However, biochemical studies on 
Inf2 indicate that it contains a WH2 domain which is involved in 
mediating its auto-inhibition [52] and that it is binding of actin 
monomers to this domain that relieves the auto-inhibition [53]. 
The initial increase in actin filament severing and 
depolymerization immediately upon platelet activation could 
therefore provide an environment for the activation of Inf2 and 
subsequent nucleation/elongation of new actin filaments. 
A further intriguing possibility is the observation that Inf2 can 
regulate the activity of mDia1 [54,55] and that this might be 
important for modulating the interaction of mDia1 with micro-
tubules [56]. The implications of this for platelets remain unclear, 
especially in the absence of mDia1 and Fhod1, but it would be 
interesting to study the role of Inf2 and Daam1 in platelet func-
tion further.
In conclusion, we have shown that loss of mDia1 and Fhod1 
causes a reduction in platelet formation and may disrupt MK 
development. In contrast platelet function is more tolerant of 
loss of these two formin family members, as in the milieu of an 
activated platelet, the formin-mediated actin polymerization 
requirements can be met by other expressed formins. It would 
therefore be interesting in future studies to investigate the con-
tributions of Daam1 and Inf2 to MK and platelet function.
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